Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability

Bias in meta-analysis detected by a simple, graphical test

Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works

Meta-analysis in clinical trials

DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works

Book Reviews: Statistical Methods for Meta-Analysis Larry V. Hedges and Ingram Olkin New York: Academic Press, 1985. xxii + 369 pp

Wasserman, S. S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,347 · see citing works

Research Diagnostic Criteria

Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946 · see citing works

Diagnostic criteria for use in psychiatric research.

Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G., & Munoz, R. A. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750190059011 · Cited by 5,491 · see citing works

Statistical Methods for Meta-Analysis.

Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,832 · see citing works

Research Diagnostic Criteria

Spitzer, R. L., Endicott, J., & Robins, E. (1978) · PsycTESTS Dataset · doi:10.1037/t04137-000 · Cited by 556 · see citing works

Recognition and management of depression in general practice: consensus statement

Paykel, E. S., & Priest, R. G. (1992) · BMJ · doi:10.1136/bmj.305.6863.1198 · Cited by 540 · see citing works

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399 · see citing works

Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study

Danish University Antidepressant Group (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90081-i · Cited by 398 · see citing works

Binding of antidepressants to human brain receptors: focus on newer generation compounds

Cusack, B. M., Nelson, A. N., & Richelson, E. (1994) · Psychopharmacology · doi:10.1007/bf02244985 · Cited by 349 · see citing works

Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.

Cohn, C. K., Shrivastava, R., Mendels, J., Cohn, J. B., Fabre, L. F., Claghorn, J. L., Dessain, E. C., Itil, T. M., & Lautin, A. (1990) · PubMed · Cited by 348 · see citing works

Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis

Gøtzsche, P. C. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90017-2 · Cited by 339 · see citing works

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

Anderson, I. M., & Tomenson, B. (1995) · BMJ · doi:10.1136/bmj.310.6992.1433 · Cited by 304 · see citing works

Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study

Gram, L. F. (1986) · Psychopharmacology · doi:10.1007/bf00172884 · Cited by 301 · see citing works

Relative mortality from overdose of antidepressants

Henry, J. A., Alexander, C., & Sener, E. K. (1995) · BMJ · doi:10.1136/bmj.310.6974.221 · Cited by 292 · see citing works

SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+ · Cited by 277 · see citing works

Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.

Reimherr, F. W., Chouinard, G., Cohn, C. K., Cole, J. O., Itil, T. M., LaPierre, Y. D., Masco, H. L., & MENDELS, J. (1990) · PubMed · Cited by 263 · see citing works

A Comparison of Fluoxetine Imipramine and Placebo in Patients with Bipolar Depressive Disorder

Cohn, J. B., COLLINS, G., ASHBROOK, E., & Wernicke, J. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198910000-00006 · Cited by 256 · see citing works

Selective serotonin reuptake inhibitors

Montgomery, S. A., Henry, J. A., McDonald, G. J., Dinan, T. G., LADER, M. H., Hindmarch, I., Clare, A. W., & Nutt, D. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400910-00008 · Cited by 254 · see citing works

Treatment of major depression

Rush, A. J. (1993) · Medical Entomology and Zoology · Cited by 250 · see citing works

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

Anderson, I. M., & Tomenson, B. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800407 · Cited by 249 · see citing works

A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.

Stark, P., & Hardison, C. D. (1985) · PubMed · Cited by 239 · see citing works

[Biological psychiatry].

Hg, R. (1992) · PubMed · Cited by 223 · see citing works

Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: A meta-analysis

Steffens, D. C., Krishnan, K. R., & Helms, M. J. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)6:1 · Cited by 194 · see citing works

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

Dunbar, G. C., Cohn, J. B., Fabre, L. F., Feighner, J. P., Fieve, R. R., MENDELS, J., & Shrivastava, R. K. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.159.3.394 · Cited by 172 · see citing works

Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.

Feighner, J. P., & Cohn, J. B. (1985) · PubMed · Cited by 170 · see citing works

Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.

Grimsley, S. R., & Jann, M. W. (1992) · PubMed · Cited by 163 · see citing works

Antidepressant Prescribing Practices of Outpatient Psychiatrists

Olfson, M., Marcus, S. C., Pincus, H. A., ZITO, J. M., Thompson, J. W., & Zarin, D. A. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.310 · Cited by 161 · see citing works

A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.

Chouinard, G. (1985) · PubMed · Cited by 157 · see citing works

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

Hotopf, M. H., Hardy, R., & Lewis, G. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.170.2.120 · Cited by 142 · see citing works

Comparative Efficacy of Antidepressants

Kasper, S. F., Fuger, J., & Möller, H. ‐. (1992) · Drugs · doi:10.2165/00003495-199200432-00004 · Cited by 139 · see citing works

Fluvoxamine and clomipramine in depressed patients A DOUBLE‐BLIND CLINICAL STUDY

Klok, C. J., Brouwer, G., van Praag, H. M., & Doogan, D. P. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00756.x · Cited by 137 · see citing works

The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis

Mittmann, N., Herrmann, N., Einarson, T. R., Busto, U. E., Lanctôt, K. L., Liu, B. A., Shulman, K. I., Silver, I., Naranjo, C. A., & Shear, N. H. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00107-9 · Cited by 135 · see citing works

A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.

Jb, C., & Wilcox, C. M. (1985) · PubMed · Cited by 133 · see citing works

Are SSRIs a Cost-Effective Alternative to Tricyclics?

Hotopf, M. H., Lewis, G., & Normand, C. E. M. (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.168.4.404 · Cited by 104 · see citing works

Acute, Subchronic and Withdrawal Sleep EEG Changes During Treatment With Paroxetine and Amitriptyline: A Double-Blind Randomized Trial in Major Depression

Staner, L., Kerkhofs, M., Detroux, D., Leyman, S., Linkowski, P., & Mendlewicz, J. (1995) · SLEEP · doi:10.1093/sleep/18.6.470 · Cited by 89 · see citing works

Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.

Dl, D., Jb, C., Walshe, T., Ck, C., Feighner, J. P., Rr, F., Jp, H., Jt, H., Ed, H., & Settle, E. C. (1992) · PubMed · Cited by 89 · see citing works

Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993–5: Table 1

Donoghue, J., Tylee, A. T., & Wildgust, H. J. (1996) · BMJ · doi:10.1136/bmj.313.7061.861 · Cited by 88 · see citing works

Controlled Trial of Amitriptyline in General Practice

Blashki, T. G., Mowbray, R. M., & Davies, B. (1971) · BMJ · doi:10.1136/bmj.1.5741.133 · Cited by 86 · see citing works

General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants

Martin, R. M., Hilton, S. R., Kerry, S., & Richards, N. (1997) · BMJ · doi:10.1136/bmj.314.7081.646 · Cited by 84 · see citing works

Paroxetine in the treatment of depression ‐ a randomized comparison with amitriptyline

Laursen, A. L., Mikkelsen, P. L., Rasmussen, S., & Honoré, P. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb01281.x · Cited by 83 · see citing works

Chronobiology and Psychiatric Disorders

Halaris, A. E. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198901000-00014 · Cited by 80 · see citing works

A double‐blind placebo‐controlled study of fluvoxamine and imipramine in out‐patients with primary depression.

Itil, T. M., Rk, S., Mukherjee, S., Coleman, B., & Michael, S. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02134.x · Cited by 80 · see citing works

A Placebo-controlled Inpatient Comparison of Fluvoxamine Maleate and Imipramine in Major Depression

Feighner, J. P., Boyer, W. F., Meredith, C. H., & HENDRICKSON, G. G. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198907000-00006 · Cited by 79 · see citing works

Fluvoxamine and chlorimipramine in endogenous depression

Wilde, J. E. M. D., & Doogan, D. P. (1982) · Journal of Affective Disorders · doi:10.1016/0165-0327(82)90009-x · Cited by 77 · see citing works

A double‐blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients

Guillibert, E., Pélicier, Y., Archambault, J. C., Chabannes, J.-P., Cierc, G., Desvilles, M., Guibert, M., Pagot, R., Poisat, J. L., & Thobie, Y. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07192.x · Cited by 75 · see citing works

Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology

Montgomery, S., Bebbington, P., Cowen, P. J., Deakin, J. F. W., FREELING, P., Hallström, C., Katona, C., King, D., Leonard, B. E., Levine, S., et al. (1993) · Journal of Psychopharmacology · doi:10.1177/0269881193007001041 · Cited by 72 · see citing works

Fluoxetine in depressed patients: a comparison with imipramine.

Bremner, J. D. (1984) · PubMed · Cited by 70 · see citing works

A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.

Feighner, J. P. (1985) · PubMed · Cited by 70 · see citing works

Fluvoxamine in the Treatment of the Older Depressed Patient; Double-blind, Placebo-controlled Data

Wakelin, J. S. (1986) · International Clinical Psychopharmacology · doi:10.1097/00004850-198607000-00005 · Cited by 69 · see citing works

A Double-Blind, Multicenter Study in Primary Care Comparing Paroxetine and Clomipramine in Patients With Depression and Associated Anxiety

Ravindran, A. V., Judge, R., Hunter, B. N., Bray, J., Morton, N. H., & The Paroxetine Study Group (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0305 · Cited by 67 · see citing works

A double‐blind controlled clinical trial comparing fluvoxamine with imipramine.

Guelfi, J., Dreyfus, J. F., & Pichot, P. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02131.x · Cited by 67 · see citing works

A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.

Dominguez, R. A., Goldstein, B. J., Jacobson, A. F., & Steinbook, R. M. (1985) · PubMed · Cited by 65 · see citing works

Fluoxetine and Desipramine in Major Depressive Disorder

Bowden, C. L., Schatzberg, A. F., ROSENBAUM, A., Contreras, S. A., SAMSON, J. A., Dessain, E. C., & Sayler, M. E. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199310000-00002 · Cited by 64 · see citing works

A Multicenter Double-Blind Trial of Paroxetine Versus Amitriptyline in Depressed Inpatients

Stuppaeck, C., Geretsegger, C., Whitworth, A. B., SCHUBERT, H., Platz, T., NIG, P. K., Hinterhuber, H., & Fleischhacker, W. W. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199408000-00003 · Cited by 64 · see citing works

A double blind comparison of the effects of fluoxetine and amitriptyline on cognitive function in elderly depressed patients

Fairweather, D. B., Kerr, J., Harrison, D. A., Moon, C. A. L., & Hindmarch, I. (1993) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470080108 · Cited by 63 · see citing works

Comparative effects of fluoxetine and amitriptyline on cardiac function.

Upward, J., Edwards, J. G., Goldie, A., & Waller, D. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03397.x · Cited by 62 · see citing works

A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice

Doogan, D. P., & Langdon, C. J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400920-00005 · Cited by 61 · see citing works

Treatment of major affective disorder with fluvoxamine.

Lapierre, Y. D., Browne, M., Horn, E., Lk, O., Sarantidis, D., Roberts, N., Badoe, K., & Tessier, P. (1987) · PubMed · Cited by 60 · see citing works

Fluoxetine in Major Depression

Kerkhofs, M., Rielaert, C., Maertelaer, V. D., Linkowski, P., Czarka, M., & MENDLEWICZ, J. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199010000-00002 · Cited by 60 · see citing works

Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing.

de Wilde, J., Mertens, C., & Wakelin, J. S. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02133.x · Cited by 59 · see citing works

A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression

Feighner, J. P., Boyer, W. F., Merideth, C., & HENDRICKSON, G. G. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198904000-00004 · Cited by 58 · see citing works

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

Geretsegger, C., Fartacek, R. R., Stuppaeck, C., Mair, M., Platz, T., & Heim, M. (1995) · Psychopharmacology · doi:10.1007/bf02246291 · Cited by 58 · see citing works

Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study

Rosenberg, C., Damsbo, N., Fuglum, E., Jacobsen, L. V., & Horsgård, S. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00007 · Cited by 58 · see citing works

Paroxetine in the treatment of melancholia and severe depression

Tignol, J., Stoker, M. J., & Dunbar, G. C. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199211000-00005 · Cited by 57 · see citing works

Response to Total Sleep Deprivation Before and During Treatment with Fluvoxamine or Maprotiline in Patients with Major Depression - Results of a Double-Blind Study

Kasper, S. F., Voll, G., Vieira, A., & Kick, H. A. (1990) · Pharmacopsychiatry · doi:10.1055/s-2007-1014496 · Cited by 55 · see citing works

Fluvoxamine Maleate in the Treatment of Depression

Claghorn, J. L., Earl, C. Q., Walczak, D. D., Stoner, K. A., Wong, L. F., Kanter, D. R., & Houser, V. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199604000-00003 · Cited by 54 · see citing works

A double‐blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder

Mullin, J. M., Vr, P.-G., & Whitehead, A. M. (1988) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1988.tb08510.x · Cited by 54 · see citing works

The prescribing of antidepressants in general practice. II: A placebo‐controlled trial of low‐dose dothiepin

Thompson, C. M., & Thompson, C. M. (1989) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470040305 · Cited by 53 · see citing works

Severity of depression and response to fluoxetine

Pande, A. C., & Sayler, M. E. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00006 · Cited by 51 · see citing works

FLUVOXAMINE

Amin, M. M., Ananth, J., Coleman, B. S., DARCOURT, G., Farkas, T., Goldstein, B. J., Lapierre, Y. O., Paykel, E. S., & Wakelin, J. S. (1984) · Clinical Neuropharmacology · doi:10.1097/00002826-198406001-00286 · Cited by 51 · see citing works

A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients

Norton, K., Sireling, L., Bhat, A., Rao, B., & Paykel, E. S. (1984) · Journal of Affective Disorders · doi:10.1016/0165-0327(84)90051-x · Cited by 49 · see citing works

Lymphocyte function in major depression

Altshuler, L. L., Plaeger-Marshall, S., Richeimer, S. H., Daniels, M., & Baxter, L. R. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb01314.x · Cited by 47 · see citing works

Double-Blind Multicenter Study of Paroxetine and Amitriptyline in Depressed Inpatients

Möller, H., Berzewski, H., Eckmann, F., Gonzalves, N., Kissling, W., Knorr, W., Ressler, P. K., Rudolf, G., Steinmeyer, E. M., Magyar, I., et al. (1993) · Pharmacopsychiatry · doi:10.1055/s-2007-1014346 · Cited by 47 · see citing works

A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients.

Mk, R., Mj, A., Savla, N., Rr, S., Jm, K., & Ashford, J. J. (1991) · PubMed · Cited by 47 · see citing works

Is Baseline Agitation a Relative Contraindication for a Selective Serotonin Reuptake Inhibitor: A Comparative Trial of Fluoxetine Versus Imipramine

TOLLEFSON, G. D., GREIST, J. H., JEFFERSON, J. W., HEILIGENSTEIN, J. H., SAYLER, M. E., TOLLEFSON, S. L., & KOBACK, K. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00003 · Cited by 47 · see citing works

A Comparison of Fluoxetine and Amitriptyline in the Treatment of Major Depression

Keegan, D. A., Bowen, R., Blackshaw, S. L., SALEH, S., Dayal, N., REMILLARD, F., Shrikhande, S., PEREZ, S. C., Boulton, A. L., RICHARDSON, S., et al. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100620-00007 · Cited by 46 · see citing works

Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients

Bouchard, J. M., Delaunay, J., Delisle, J. ‐., Grasset, N., Mermberg, P. F., Molczadzki, M., Pagot, R., Richou, H., Robert, G., Ropert, R., et al. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02923.x · Cited by 46 · see citing works

Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.

Lydiard, R. B., Laird, L. K., Morton, W. A., Steele, T. E., Kellner, C. H., Mt, L., & Jc, B. (1989) · PubMed · Cited by 46 · see citing works

Fluoxetine vs Amitriptyline in the Treatment of Depressed Out-patients

Laakmann, G., Blaschke, D., Engel, R. R., & Schwarz, A. (1988) · The British Journal of Psychiatry · doi:10.1192/s0007125000297316 · Cited by 44 · see citing works

A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.

March, J. S., Kobak, K. A., Jefferson, J. W., Mazza, J., & Greist, J. H. (1990) · PubMed · Cited by 44 · see citing works

The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.

Rs, N., Perel, J. M., Pollock, B. G., & Dj, K. (1990) · PubMed · Cited by 44 · see citing works

Recognition and management of narcolepsy

Stores, G. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.81.6.519 · Cited by 43 · see citing works

A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression

Roth, D. A., Mattes, J. A., Sheehan, K. H., & Sheehan, D. V. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90078-u · Cited by 43 · see citing works

A Controlled Comparison of Fluoxetine and Amitriptyline in Depressed Out-patients

Young, J. P. R., Coleman, A., & Lader, M. H. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.3.337 · Cited by 42 · see citing works

A Double-Blind Multicentre Study of Paroxetine and Amitriptyline in Depressed Outpatients

Bignamini, A., & Rapisarda, V. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206004-00008 · Cited by 42 · see citing works

A double‐blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.

DICK, P. H., & Ferrero, E. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02132.x · Cited by 42 · see citing works

A Comparative Trial of a New Antidepressant, Fluoxetine

Levine, S., Deo, R., & Mahadevan, K. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.150.5.653 · Cited by 41 · see citing works

A double‐blind comparison of citalopram (Lu 10–171) and amitriptyline in depressed patients

Gravem, A., Amthor, K.-F., Astrup, C., Elgen, K., GJESSING, L. R., Gunby, B., Pettersen, R., Kyrdalen, L., Vaadal, J., Øfsti, E., et al. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02821.x · Cited by 41 · see citing works

Fluvoxamine. A review of its safety profile in world-wide studies

Wagner, W., Zaborny, B. A., & Gray, T. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400940-00001 · Cited by 40 · see citing works

A Comparison of the Antidepressant Action of Citalopram and Amitriptyline

Shaw, D., Thomas, D. R., Briscoe, M. H., Crimmins, R., Harris, B., Lovett, J., Raj, M., Lloyd, A. T., Osborne, C., Hughes, G., et al. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.149.4.515 · Cited by 40 · see citing works

Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice

Øhrberg, S., Christiansen, P. E., Severin, B., Calberg, H., Nilakantan, B., Borup, A., Søgaard, J., Larsen, S. B., Loldrup, D., Bahr, B., et al. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03294.x · Cited by 40 · see citing works

The efficacy of fluvoxamine in patients with severe depression

Ottevanger, E. A. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90080-9 · Cited by 39 · see citing works

A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia

Heiligenstein, J. H., Tollefson, G. D., & Faries, D. E. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00007 · Cited by 38 · see citing works

Fluvoxamine and imipramine in the treatment of depressive patients: A double-blind controlled study

Gonella, G., Baignoli, G., & Ecari, U. (1990) · Current Medical Research and Opinion · doi:10.1185/03007999009111499 · Cited by 38 · see citing works

A Double-blind Comparative Study of Fluoxetine and Dothiepin in the Treatment of Depression in General Practice

CORNE, S. J., & Hall, J. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198907000-00007 · Cited by 38 · see citing works

A Double-Blind Comparative Clinical Trial of Citalopram vs Maprotiline in Hospitalized Depressed Patients

Timmerman, L., de Beurs, P., TAN, B. K., Leijnse-Ybema, H. J., Sánchez, C., Petersen, H. E. H., & Stuart, M. (1987) · International Clinical Psychopharmacology · doi:10.1097/00004850-198707000-00006 · Cited by 38 · see citing works

Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.

Lf, F., Mb, S., & Tm, I. (1991) · PubMed · Cited by 38 · see citing works

Fluoxetine Efficacy vs Comparative Drugs: An Overview

LADER, M. H. (1988) · The British Journal of Psychiatry · doi:10.1192/s0007125000297298 · Cited by 37 · see citing works

A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice

Moon, C. A. L., Jago, W., Wood, K., & Doogan, D. P. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800306 · Cited by 37 · see citing works

A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression

de Jonghe, F., Ravelli, D. P., & Tuynman-Qua, H. G. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014440 · Cited by 36 · see citing works

Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients

Fabre, L., Birkhimer, L. J., Zaborny, B. A., Wong, L. F., & Kapik, B. M. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606000-00006 · Cited by 36 · see citing works

Paroxetine in the Elderly: A Comparative Meta-Analysis against Standard Antidepressant Pharmacotherapy

Dunbar, G. C. (2008) · Pharmacology · doi:10.1159/000139327 · Cited by 35 · see citing works

Paroxetine and amitriptyline in the treatment of depression in general practice

Christiansen, P. E., Behnke, K., Black, C. H., Öhrström, J. K., Bork‐Rasmussen, H., & Nilsson, J.-E. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10623.x · Cited by 33 · see citing works

A double‐blind study of the comparative antidepressant effect of paroxetine and amitriptyline

Kuhs, H., & Rudolf, G. A. E. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07198.x · Cited by 32 · see citing works

A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder

Nielsen, B. M., Behnke, K., Arup, P., Christiansen, P. E., Geisler, A. E., Ipsen, E. Ø., Maach‐Møller, B., & Øhrberg, S. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03370.x · Cited by 32 · see citing works

Double-Blind Comparative Study of Paroxetine and Amitriptyline in Depressed Patients of a University Psychiatric Outpatient Clinic (Pilot Study)

Battegay, R., Hager, M., & Rauchfleisch, U. (2008) · Neuropsychobiology · doi:10.1159/000118159 · Cited by 32 · see citing works

Fluoxetine versus amitriptyline in the treatment of major depression

Beasley, C. M., Sayler, M. E., & Potvin, J. H. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00002 · Cited by 31 · see citing works

The impact of sertraline, desipramine, and placebo on psychomotor functioning in depression

Ravindran, A. V., Teehan, M. D., Bakish, D., Yatham, L. N., O’Reilly, R., Fernando, M. L. D., Manchanda, R., Charbonneau, Y., & Buttars, J. A. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100404 · Cited by 31 · see citing works

Randomized Double-Blind Study of Fluvoxamine and Maprotiline in Treatment of Depression

de Jonghe, F., Swinkels, J. A., & Tuynman-Qua, H. G. (1991) · Pharmacopsychiatry · doi:10.1055/s-2007-1014428 · Cited by 31 · see citing works

A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness

Robertson, M. M., Abou‐Saleh, M. T., Harrison, D. A., Nairac, B. L., Edwards, D. R. L., Lock, T., Burns, R. A., & Katona, C. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800205 · Cited by 31 · see citing works

TREATMENT OF MAJOR DEPRESSION IN GENERAL PRACTICE: A DOUBLE‐BLIND COMPARISON OF PAROXETINE AND LOFEPRAMINE

Moon, C., & Vince, M. (1996) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1996.tb09542.x · Cited by 30 · see citing works

A 12‐week double‐blind multi‐centre study of paroxetine and imipramine in hospitalized depressed patients

Arminen, S.-L., Ikonen, U., Pulkkinen, P., Leinonen, E. V. J., Mahlanen, A., Koponen, H., Kourula, K., Ryyppö, J., Korpela, V., Lehtonen, M. L., et al. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01533.x · Cited by 30 · see citing works

A double‐blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients

Bascara, L. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07196.x · Cited by 28 · see citing works

A double‐blind clinical trial of fluvoxamine and imipramine in patients with primary depression

Guy, W., Wilson, W. H., Ban, T. A., King, D. L., Manov, G., & Fjetland, O. K. (1984) · Drug Development Research · doi:10.1002/ddr.430040203 · Cited by 28 · see citing works

Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline.

Altamura, A. C., Percudani, M., Guercetti, G., & INVERNIZZI, G. (1989) · PubMed · Cited by 27 · see citing works

Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial

Noguera, R., Altuna, R., Álvarez, E., Ayuso, J. L., Casais, L., & Udina, C. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90045-t · Cited by 27 · see citing works

The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double‐blind comDarison with amitriptyline in I depressed outpatients

Gagiano, C. A., Muller, P. G. M., Fourie, J., & Roux, J. F. L. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07191.x · Cited by 27 · see citing works

A Multicentre Double Blind Trial of Fluoxetine versus Amitriptyline in the Treatment of Depressive Illness

Judd, F. K., Moore, K., Norman, T. R., Burrows, G. D., Gupta, R. K., & Parker, G. (1993) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679309072123 · Cited by 25 · see citing works

Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements

Nielsen, O. A., Morsing, I., Petersen, J. S., Larsen, T., Møller, S. E., Manniche, P. M., Skausig, O. B., Bille, N., Fredslund‐Andersen, F., Jensen, E., et al. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb03136.x · Cited by 24 · see citing works

Fluoxetine versus clomipramine in major depressive disorders.

Ropert, R. (1989) · PubMed · Cited by 24 · see citing works

Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.

Ottevanger, E. A. (1995) · PubMed · Cited by 23 · see citing works

Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.

Poelinger, W., & Haber, H. L. (1989) · PubMed · Cited by 22 · see citing works

Double-blind comparison of fluvoxamine and imipramine in depressed patients

Amore, M., Bellini, M., Berardi, D., Berlinzani, L., Cerviño, G., Cremonini, A., Ferrari, G. R. A., & Innamorati, A. (1989) · CINECA IRIS Institutial Research Information System (University of Genoa) · Cited by 22 · see citing works

Are in‐patient depressives more often of the melancholic subtype?

Stage, K. B., Bech, P., Gram, L. F., Kragh-Sørensen, P., Rosenberg, C., & Øhrberg, S. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10115.x · Cited by 22 · see citing works

Depression and associated anxiety in primary care: A double-blind comparison of paroxetine and amitriptyline

Stott, P., Blagden, M. D., & Aitken, C. A. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90100-z · Cited by 21 · see citing works

A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.

Guy, W., Wh, W., Ban, T. A., King, D. L., Manov, G., & Ok, F. (1984) · PubMed · Cited by 21 · see citing works

A double‐blind comparative study of sertraline and amitriptyline in outpatients with major depressive episodes

Bersani, G., Rapisarda, V., Ciani, N., Bertolino, A., & Sorge, G. (1994) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470090108 · Cited by 21 · see citing works

[Multicenter double-blind study comparing the efficacy and tolerance of paroxetine and clomipramine in reactive depression in the elderly patient].

Pélicier, Y., & Schaeffer, P. (1994) · PubMed · Cited by 20 · see citing works

Meta‐analysis of early phase I1 studies with paroxetine in hospitalized depressed patients

Byrne, M. M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07194.x · Cited by 20 · see citing works

Perspectives in Clinical Psychopharmacology of Amitriptyline and Fluvoxamine

Gasperini, M., Gatti, F., Bellini, L., Anniverno, R., & Smeraldi, E. (2008) · Neuropsychobiology · doi:10.1159/000118918 · Cited by 20 · see citing works

A Double-blind Multi-centre Trial of Fluoxetine and Dothiepin in Major Depressive Illness

SOUTH WALES ANTIDEPRESSANT DRUG TRIAL GROUP (1988) · International Clinical Psychopharmacology · doi:10.1097/00004850-198801000-00006 · Cited by 18 · see citing works

A double-blind study of fluoxetine and imipramine in major depression.

Bressa, G. M., Brugnoli, R., & Pancheri, P. (1989) · PubMed · Cited by 18 · see citing works

An Italian multicenter experience with fluvoxamine, a new antidepressant drug, versus imipramine

Bramanti, P., Ricci, R. M., Roncari, R., Bilone, F., Inga, F., Teti, V., Cristofaro, A. M. D., Ceccarelli, G., Perri, R. D., & Candela, L. (1988) · Current Therapeutic Research · Cited by 17 · see citing works

An Overview of Paroxetine in the Elderly

Dünner, D. L. (2009) · Gerontology · doi:10.1159/000213617 · Cited by 17 · see citing works

Comparison of fluoxetine and desipramine in depressed outpatients

Remick, R. A., Claman, J., Reesal, R. T., Gibson, R. E., Agbayewa, M. O., Lam, R. W. M., & Keller, F.-E. (1993) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80653-8 · Cited by 17 · see citing works

Comparison of fluvoxamine and amitriptyline in depressed outpatients

Remick, R. A., Reesal, R. T., Oakander, M. A., Allen, J., Claman, J., Ramirez, C. E., Perry, K., & Keller, F.-E. (1994) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80168-7 · Cited by 17 · see citing works

A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders.

Tamminen, T., & Vv, L. (1989) · PubMed · Cited by 16 · see citing works

Fluoxetine versus imipramine.

Loeb, C., Albano, C., & Gandolfo, C. (1989) · PubMed · Cited by 16 · see citing works

The importance of accidents in evaluating the cost of SSRIs

Hale, A. S. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199409000-00008 · Cited by 16 · see citing works

The efficacy and safety of sertraline versus imipramine in outpatients with major depression: a six month double-blind, parallel multicenter study

Fontaine, R. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90658-h · Cited by 15 · see citing works

The place of obsessive compulsive disorder in the diagnostic hierarchy

Montgomery, S. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206001-00005 · Cited by 14 · see citing works

Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders.

Manna, V., Martucci, N., & AGNOLI, A. (1989) · PubMed · Cited by 14 · see citing works

The efficacy of fluoxetine versus maprotiline in depressed patients and by dose

Kuha, S., Mehtonen, O. ‐., Henttonen, A., & Naarala, M. (1991) · Nordic Journal of Psychiatry · doi:10.3109/08039489109103274 · Cited by 14 · see citing works

The efficacy of fluvoxamine in patients with severe depression

Ottevanger, E. A. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199202001-00665 · Cited by 13 · see citing works

[Efficacy and safety of fluoxetine versus clomipramine in ambulatory patients with a depressive syndrome in a clinical trial with private practitioners].

Pakesch, G., & Dossenbach, M. R. K. (1991) · PubMed · Cited by 12 · see citing works

Secondary and Meta-Analysis of the Efficacy of Non-Tricyclic Antidepressants

Möller, H., & Haug, G. (1988) · Pharmacopsychiatry · doi:10.1055/s-2007-1017009 · Cited by 11 · see citing works

β2-Adrenoceptor antagonism in anxiety

Cooper, S. J., Kelly, C., McGilloway, S., & Gilliland, A. E. (1990) · European Neuropsychopharmacology · doi:10.1016/0924-977x(90)90016-4 · Cited by 10 · see citing works

Treatment of severe major depression: A double-blind study of sertraline and clomipramine

Lépine, J., & Wiseman, R. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)87872-2 · Cited by 7 · see citing works

Sertraline and nortriptyline: Heart rate, cognitive improvement and quality of life in depressed elderly

McEntee, W. J., Ko, G., & Richter, E. M. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)87466-9 · Cited by 7 · see citing works

Paroxetine and imipramine: A 12-week, double-blind, multicentre study in hospitalized depressed patients

Arminen, S.-L., Ikonen, U., Pulkkinen, M., Leinonen, E. V. J., Mahlanen, A., Koponen, H., Kourula, K., Ryyppö, J., Korpela, V., Lehtonen, M., et al. (1992) · Nordic Journal of Psychiatry · doi:10.3109/08039489209101158 · Cited by 6 · see citing works

Renal disease and acid-suppressing drugs

Rodriguez, L. A. G., Wallander, M.-A. A., Johanson, S., & Björck, S. (1997) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(sici)1099-1557(199707)6:4 · Cited by 3 · see citing works

PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder

Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,372 · see citing works

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

Anderson, I. M., Ferrier, I. N., Baldwin, R., Cowen, P. J., Howard, L. M., Lewis, G., Matthews, K., McAllister-Williams, H., Peveler, R. C., Scott, J. L., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 901 · see citing works

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842 · see citing works

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759 · see citing works

Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors

Bymaster, F. P. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00298-6 · Cited by 716 · see citing works

The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature

Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650 · see citing works

X-ray structure of dopamine transporter elucidates antidepressant mechanism

Penmatsa, A., Wang, K. H., & Gouaux, E. (2013) · Nature · doi:10.1038/nature12533 · Cited by 615 · see citing works

A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients With Ongoing Depression Despite Apparently Adequate Treatment With Standard Drugs

Peet, M., & Horrobin, D. F. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.913 · Cited by 615 · see citing works

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

Vaswani, M., Linda, F. K., & Ramesh, S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00338-x · Cited by 612 · see citing works

Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988–2010

Charlesworth, C. J., Smit, E., Lee, D. S. H., Alramadhan, F., & Odden, M. C. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv013 · Cited by 570 · see citing works

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 549 · see citing works

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis

Smith, D. D., Dempster, C., Glanville, J., Freemantle, N., & Anderson, I. M. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.5.396 · Cited by 537 · see citing works

Treatment and prevention of depression

Hollon, S. D., Thase, M. E., & Markowitz, J. C. (2002) · Psychological Science in the Public Interest · doi:10.1111/1529-1006.00008 · Cited by 511 · see citing works

Sertraline versus other antidepressive agents for depression

Cipriani, A., Ferla, T. L., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R. C., McGuire, H., & Barbui, C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub4 · Cited by 510 · see citing works

Quality of life in patients with multiple sclerosis

Janardhan, V., & Bakshi, R. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00312-x · Cited by 489 · see citing works

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

Creed, F., Fernandes, L., Guthrie, E., Palmer, S., Ratcliffe, J., Read, N., Rigby, C., Thompson, D., & Tomenson, B. (2003) · Gastroenterology · doi:10.1053/gast.2003.50055 · Cited by 443 · see citing works

The Medical Management of Depression

Mann, J. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050730 · Cited by 423 · see citing works

Neurobiology of depression: an integrated view of key findings

Maletic, V., Robinson, M., Oakes, T. M. M., Iyengar, S., Ball, S. G., & Russell, J. D. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01602.x · Cited by 387 · see citing works

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update

Spina, E., Santoro, V., & D’Arrigo, C. (2008) · Clinical Therapeutics · doi:10.1016/s0149-2918(08)80047-1 · Cited by 362 · see citing works

Hot flushes

Stearns, V., Ullmer, L., López, J. F., Smith, Y. R., Isaacs, C. J., & Hayes, D. F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11774-0 · Cited by 355 · see citing works

Obsessive-compulsive disorder

Stein, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09620-4 · Cited by 352 · see citing works

Meta-analytical studies on new antidepressants

Anderson, I. M. (2001) · British Medical Bulletin · doi:10.1093/bmb/57.1.161 · Cited by 350 · see citing works

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder

Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150599 · Cited by 340 · see citing works

Antidepressant-Induced Sexual Dysfunction

Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320 · see citing works

Sertraline versus other antidepressive agents for depression

Cipriani, A., Ferla, T. L., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R. C., McGuire, H., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub2 · Cited by 319 · see citing works

Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents

Papakostas, G. I., Thase, M. E., Fava, M., Nelson, J. C., & Shelton, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.027 · Cited by 308 · see citing works

The burden of severe depression: A review of diagnostic challenges and treatment alternatives

Nemeroff, C. B. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.008 · Cited by 295 · see citing works

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

Kennedy, S. H., & Emsley, R. A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.09.002 · Cited by 294 · see citing works

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

Bloch, M. H., & Hannestad, J. O. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.100 · Cited by 293 · see citing works

Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men

Haney, E. M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1246 · Cited by 286 · see citing works

Serotonin 5-HT2C Receptors as a Target for the Treatment of Depressive and Anxious States: Focus on Novel Therapeutic Strategies

Millan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 285 · see citing works

Treatment of mood disorders

Nemeroff, C. B., & Owens, M. J. (2002) · Nature Neuroscience · doi:10.1038/nn943 · Cited by 282 · see citing works

Screening for Depression in Adult Patients in Primary Care Settings: A Systematic Evidence Review

O’Connor, E., Whitlock, E. P., Beil, T. L., & Gaynes, B. N. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-11-200912010-00007 · Cited by 279 · see citing works

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

Detke, M. J., Wiltse, C. G., Mallinckrodt, C. H., McNamara, R. K., Demitrack, M. A., & Bitter, I. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.01.002 · Cited by 283 · see citing works

Clashing diagnostic approaches: DSM-ICD versus RDoC

Lilienfeld, S. O., & Treadway, M. T. (2016) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-021815-093122 · Cited by 275 · see citing works

Amitriptyline for depression

Guaiana, G., Barbui, C., & Hotopf, M. H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004186.pub2 · Cited by 273 · see citing works

Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder

Olié, J., & Kasper, S. F. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007766 · Cited by 257 · see citing works

The role of monoamines in the actions of established and “novel” antidepressant agents: a critical review

Millan, M. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.038 · Cited by 255 · see citing works

Fluoxetine versus other types of pharmacotherapy for depression

Magni, L. R., Purgato, M., Gastaldon, C., Papola, D., Furukawa, T. A., Cipriani, A., & Barbui, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub3 · Cited by 251 · see citing works

The role of the brain reward system in depression

Naranjo, C. A., Tremblay, L. K., & Busto, U. E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00156-7 · Cited by 245 · see citing works

Side effects of antidepressants during long-term use in a naturalistic setting

Bet, P. M., Hugtenburg, J. G., Penninx, B. W. J. H., & Hoogendijk, W. J. G. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.001 · Cited by 239 · see citing works

Escitalopram Therapy for Major Depression and Anxiety Disorders

Baldwin, D. S., Reines, E. H., Guiton, C., & Weiller, E. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k089 · Cited by 228 · see citing works

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis

Kennedy, S. H., Andersen, H. F., & Lam, R. W. M. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0615 · Cited by 216 · see citing works

Tolerability and adherence issues in antidepressant therapy

Masand, P. S. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80220-5 · Cited by 215 · see citing works

Antidepressants for treating depression in dementia

Bains, J., Birks, J., & Dening, T. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003944 · Cited by 214 · see citing works

The Burden of Major Depression Avoidable by Longer-term Treatment Strategies

Vos, T., Haby, M. M., Barendregt, J. J., Kruijshaar, M., Corry, J., & Andrews, G. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1097 · Cited by 213 · see citing works

Pharmacology of antidepressants

Richelson, E. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.5.511 · Cited by 210 · see citing works

Monoamine Transporter Gene Polymorphisms and Antidepressant Response in Koreans With Late-Life Depression

Kim, H. R., Lim, S., Kim, S., Kim, J., Chang, Y. H., Carroll, B. J., & Kim, D. K. (2006) · JAMA · doi:10.1001/jama.296.13.1609 · Cited by 202 · see citing works

Positive Spillovers and Free Riding in Advertising of Prescription Pharmaceuticals: The Case of Antidepressants

Shapiro, B. T. (2017) · Journal of Political Economy · doi:10.1086/695475 · Cited by 202 · see citing works

Dual- and Triple-Acting Agents for Treating Core and Co-morbid Symptoms of Major Depression: Novel Concepts, New Drugs

Millan, M. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.039 · Cited by 197 · see citing works

Exposure to Tricyclic and Selective Serotonin Reuptake Inhibitor Antidepressants and the Risk of Hip Fracture

Hubbard, R. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg114 · Cited by 197 · see citing works

Antidepressants for depression in physically ill people

Rayner, L., Price, A. C., Evans, A., Valsraj, K. M., Higginson, I. J., & Hotopf, M. H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007503.pub2 · Cited by 192 · see citing works

Relative efficacy of psychotherapy and combined therapy in the treatment of depression: A meta-analysis

de Maat, S. M., Dekker, J., Schoevers, R. A., & de Jonghe, F. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2006.10.008 · Cited by 192 · see citing works

A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples

Prado, C. E., Watt, S., & Crowe, S. F. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9369-5 · Cited by 188 · see citing works

Prescribing patterns of antidepressants in Europe: results from the factors influencing depression endpoints research (FINDER) study

Bauer, M., Monz, B. U., Montejo, A. L., Quail, D., Dantchev, N., Demyttenaere, K., Garcia-Cebrian, A., Grassi, L., Perahia, D. G. S., Reed, C., et al. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2007.11.001 · Cited by 186 · see citing works

Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

Uher, R., Maier, W., Hauser, J., Marušič†, A., Schmael, C., Mors, O. N., Henigsberg, N., Souery, D., Placentino, A., Rietschel, M., et al. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.057554 · Cited by 183 · see citing works

DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS

SAFER, D. J. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200209000-00002 · Cited by 180 · see citing works

Public attitudes toward depression and help-seeking in four European countries baseline survey prior to the OSPI-Europe intervention

Coppens, E., Audenhove, C. V., Scheerder, G., Arensman, E., Coffey, C., Costa, S., Koburger, N., Gottlebe, K., Gusmão, R. M., O’Connor, R. C., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.013 · Cited by 178 · see citing works

Structural biology of solute carrier (SLC) membrane transport proteins

Bai, X., Moraes, T. F., & Reithmeier, R. A. F. (2017) · Molecular Membrane Biology · doi:10.1080/09687688.2018.1448123 · Cited by 177 · see citing works

A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?

Walker, F. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.002 · Cited by 175 · see citing works

Antidepressants for treating depression in dementia

Dudas, R., Malouf, R., McCleery, J., & Dening, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003944.pub2 · Cited by 175 · see citing works

The Efficacy of Adjunctive<i>N</i>-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Dean, O. M., Cotton, S. M., Jeavons, S., Tanious, M., Kohlmann, K., Hewitt, K., Moss, K., Allwang, C., Schapkaitz, I., et al. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08454 · Cited by 172 · see citing works

Efficacy of treatment in older depressed patients: A systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants

Kok, R. M., Nolen, W. A., & Heeren, T. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.036 · Cited by 167 · see citing works

Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression.

Logan, A. C. (2003) · PubMed · Cited by 163 · see citing works

Clinical Guidelines for the Treatment of Depressive Disorders IV. Medications and Other Biological Treatments

Kennedy, S. H., Lam, R. W. M., Cohen, N. L., Ravindran, A. V., & The CANMAT Depression Work Group (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674372001460101004 · Cited by 162 · see citing works

Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs

Nemeroff, C. B., Entsuah, R., Benattia, I., Demitrack, M. A., Sloan, D. M., & Thase, M. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.027 · Cited by 161 · see citing works

Paroxetine Prevents Loss of Nigrostriatal Dopaminergic Neurons by Inhibiting Brain Inflammation and Oxidative Stress in an Experimental Model of Parkinson’s Disease

Chung, Y. C., Kim, S. R., & Jin, B. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000208 · Cited by 159 · see citing works

Tolerability issues during long-term treatment with antidepressants

Cassano, P., & Fava, M. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490281618 · Cited by 154 · see citing works

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression

Stahl, S. M., Entsuah, R., & Rudolph, R. L. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01425-7 · Cited by 150 · see citing works

Advances in small molecules promoting neurotrophic function

PRICE, R., MILNE, S., SHARKEY, J., & MATSUOKA, N. (2007) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2007.03.005 · Cited by 148 · see citing works

Evidence-Based Practices in Geriatric Mental Health Care

Bartels, S. J., Citters, A. D. V., Oxman, T. E., Schneider, L. S., Areán, P. A., Alexopoulos, G. S., & Jeste, D. V. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.11.1419 · Cited by 146 · see citing works

Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder

Cutler, A. J., Mattingly, G. W., & Maletic, V. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02514-2 · Cited by 147 · see citing works

Prevalence and outcome of partial remission in depression

Tranter, R., O’Donovan, C., Chandarana, P. C., & Kennedy, S. H. (2002) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0242 · Cited by 145 · see citing works

Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders

Mendlewicz, J. (2009) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802503086 · Cited by 143 · see citing works

General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction

Tata, L. J., West, J., Smith, C., Farrington, P., Card, T. R., Smeeth, L. L., & Hubbard, R. (2005) · Heart · doi:10.1136/hrt.2004.037457 · Cited by 143 · see citing works

Treatment of menopausal symptoms: what shall we do now?

Hickey, M., Davis, S. R., & Sturdee, D. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66519-1 · Cited by 142 · see citing works

Escitalopram in the treatment of major depressive disorder: A meta-analysis

Kennedy, S. H., Andersen, H. F., & Thase, M. E. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802622726 · Cited by 141 · see citing works

Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis

Mészáros, Á., Czobor, P., Bálint, S., Komlósi, S., Simon, V., & Bitter, I. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990198 · Cited by 138 · see citing works

Brain Systems Underlying Susceptibility to Helplessness and Depression

Shumake, J., & Gonzalez-Lima, F. (2003) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582303259057 · Cited by 135 · see citing works

Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats

Kitaichi, Y., Inoue, T., Nakagawa, S., Boku, S., Kakuta, A., Izumi, T., & Koyama, T. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.08.026 · Cited by 136 · see citing works

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features

Mallinckrodt, C. H., Watkin, J. G., Liu, C., Wohlreich, M. M., & Raskin, J. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-1 · Cited by 134 · see citing works

The Depression Treatment Cascade in Primary Care: A Public Health Perspective

Pence, B. W., O’Donnell, J. K., & Gaynes, B. N. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0274-y · Cited by 133 · see citing works

Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: A translational link to humans

Neill, J. C., Harte, M., Haddad, P. M., Lydall, E. S., & Dwyer, D. M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.011 · Cited by 132 · see citing works

Randomized Trial of Sertraline Versus Venlafaxine XR in Major Depression: Efficacy and Discontinuation Symptoms

Sir, A., D'Souza, R. F., Uguz, S., George, T., Vahip, S., Hopwood, M., Martin, A. J., Lam, W., & Burt, T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1015 · Cited by 129 · see citing works

Fluoxetine versus other types of pharmacotherapy for depression

Cipriani, A., Brambilla, P., Furukawa, T. A., Geddes, J. R., Gregis, M., Hotopf, M. H., Malvini, L., & Barbui, C. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub2 · Cited by 130 · see citing works

The Deficit of Pain Inhibition in Fibromyalgia Is More Pronounced in Patients With Comorbid Depressive Symptoms

de Souza, J. B., Potvin, S., Goffaux, P., Charest, J., & Marchand, S. (2009) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318183cfa4 · Cited by 129 · see citing works

Depression and the risk for dementia

Kessing, L. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328356c368 · Cited by 130 · see citing works

Effect of various classes of antidepressants in behavioral paradigms of despair

Kulkarni, S. K., & Dhir, A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.05.002 · Cited by 127 · see citing works

Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs

Nemeroff, C. B., Entsuah, R., Benattia, I., Demitrack, M. A., Sloan, D. M., & Thase, M. E. (2010) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.8.4.foc592 · Cited by 126 · see citing works

Efficacy markers in depression

Harmer, C. J., Cowen, P. J., & Goodwin, G. M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110367722 · Cited by 122 · see citing works

A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation

Fornaro, M., Prestía, D., Colicchio, S., & Perugi, G. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246227 · Cited by 119 · see citing works

Relative efficacy of psychotherapy and pharmacotherapy in the treatment of depression: A meta-analysis

de Maat, S. C. M., Dekker, J., Schoevers, R. A., & de Jonghe, F. E. R. E. R. (2006) · Psychotherapy Research · doi:10.1080/10503300600756402 · Cited by 116 · see citing works

Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression

Souery, D., Serretti, A., Calati, R., Oswald, P., Massat, I., Konstantinidis, A., Linotte, S., Bollen, J., Demyttenaere, K., Kasper, S. F., et al. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182228619 · Cited by 118 · see citing works

Motor activity and autonomic cardiac functioning in major depressive disorder

Volkers, A. C. W. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00066-6 · Cited by 116 · see citing works

LC–MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma

de Castro, A., Concheiro, M., Quintela, O., Cruz, A., & López‐Rivadulla, M. (2008) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2008.05.024 · Cited by 117 · see citing works

Psychosocial and pharmacological interventions for depressed adults in primary care: A critical review

Wolf, N. J., & Hopko, D. R. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.04.004 · Cited by 114 · see citing works

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo‐controlled clinical trials

Hudson, J. I., Wohlreich, M. M., Kajdasz, D. K., Mallinckrodt, C. H., Watkin, J. G., & Martynov, O. V. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.696 · Cited by 116 · see citing works

Cost-Effectiveness of Cognitive–Behavioural Therapy and Drug Interventions for Major Depression

Vos, T., Corry, J., Haby, M. M., Carter, R., & Andrews, G. (2005) · Australian &amp; New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01652.x · Cited by 114 · see citing works

Selective Serotonin Reuptake Inhibitors

Mozayani, M. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-222-9_6 · Cited by 113 · see citing works

Pseudobulbar affect: prevalence and management

Simmons, Z., & Ahmed, A. (2013) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s53906 · Cited by 112 · see citing works

Depression and associated anxiety in primary care: A double-blind comparison of paroxetine and amitriptyline

Stott, P., Blagden, M. D., & Aitken, C. A. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90100-z · Cited by 21 · see citing works

SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+ · Cited by 277 · see citing works

The efficacy and safety of sertraline versus imipramine in outpatients with major depression: a six month double-blind, parallel multicenter study

Fontaine, R. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90658-h · Cited by 15 · see citing works

Review: selective serotonin reuptake inhibitors are as effective as tricyclic antidepressants overall but may be less effective in some patient subgroups

Nolen, W. A. (2000) · Evidence-Based Mental Health · doi:10.1136/ebmh.3.4.106

Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis

MacGillivray, S., Arroll, B., Hatcher, S., Ogston, S., Reid, I., Sullivan, F., Williams, B., & Crombie, I. (2003) · BMJ · doi:10.1136/bmj.326.7397.1014 · Cited by 265 · see citing works